Skip to main content
. 2007 May;176(1):209–220. doi: 10.1534/genetics.106.067983

TABLE 1.

Genetic modifiers of Ppt1-induced degeneration

Gene Mammalian homolog Line Insertion Modificationa Verificationb Loss-of-function allelesc
Endocytosis/trafficking
Endophilin A Endophilin A EP(3)464 91D4 Enh UAS endoAΔ4/NE
CG14709 Multidrug resistance-associated protein EP(3)430 86E11 Enh In situ NA
Blue cheese ALFY EY(3)2503 26A6 Enh In situ NA
CG5991 Phosphatidylserine decarboxylase EY(3)3559 95D5 Enh In situ NA
CG32138 Formin-like 2 EY(3)3931 70D1 Enh In situ NA
Ubiquitination
Fat facets Ubiquitin protease 9 EY(3)2018 100E1 Enh UAS fafBX4/NE
UbcE2H Ubc-E2H EP(X)1303 7D6 Sup In situ NA
CG7023 Ubiquitin protease 12-like EY(3)249 94C4-6 Sup In situ NA
Cell adhesion
Myospheroid β-integrin EP(X)1033 7D3-5 Enh UAS mys1/NE
Fasciclin 2 NCAM2 EP(X)1462 4B1-3 Sup UAS fasIIeb112/NE
Miniature Novel EP(X)406 10D8 Sup In situ m1/NE
Signaling pathways
Misshapen Ste20-related kinase EP(3)549 62E6-7 Enh UAS msn102/NE
Kayak FosB EY(3)283 99C2 Sup UAS kaysro-1/NE
Saxophone TGF-β receptor type I EY(2)4377 43E18 Sup UAS sax5/NE
Mesr4 Novel EP(2)386 54C3-7 Sup In situ NA
Fs(1)N Novel EP(X)1336 1F01-02 Sup In situ fs(1)N1/E
Miscellaneous
Hsc70-3 BiP chaperone EP(X)1507 10E3-4 Sup In situ NA
CG18177 N-acetyltransferase EP(3)3301 67C5 Enh In situ NA
CG3654 Novel EY(3)142 67B9 Enh In situ NA
CG5859 Integrator complex subunit 8 EP(2)2090 53D13 Sup In situ NA
a

Enh, enhancer; Sup, suppressor.

b

UAS, published line; In situ, In situ hybridization.

c

Loss-of-function alleles used for each gene; NE, no effect; E, enhance; NA, no specific alleles available.